Literature DB >> 25796558

Multiplex gastrointestinal pathogen panels: implications for infection control.

Kenneth H Rand1, Elizabeth E Tremblay2, Mari Hoidal3, Lori B Fisher4, Katrina R Grau5, Stephanie M Karst5.   

Abstract

In the acute care hospital inpatient setting, there is a wide variety of causes for both infectious and noninfectious diarrhea. However, without molecular assays for the wide range of agents causing gastroenteritis, there is no reliable way to determine which individuals should be placed in contact precautions, as recommended by CDC. We tested 158 inpatient diarrheal stool specimens with the FilmArray GI Panel (BioFire Diagnostics, Salt Lake City, UT, USA) that had been stored at -70°C after testing negative by conventional methods for Clostridium difficile and/or rotavirus. We found that 22.2% had at least 1 other infectious agent detected, and 60% of these patients were never placed in appropriate isolation for a total of 109 patient-days. In addition, 20.3% of patients with negative GI panel results could have been removed from isolation. Use of multiplex gastrointestinal panels may improve decisions regarding patient isolation and reduce nosocomial transmission.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  GI panel; Infection control; Norovirus

Mesh:

Year:  2015        PMID: 25796558     DOI: 10.1016/j.diagmicrobio.2015.01.007

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN: 0732-8893            Impact factor:   2.803


  22 in total

Review 1.  Multiplex Molecular Panels for Diagnosis of Gastrointestinal Infection: Performance, Result Interpretation, and Cost-Effectiveness.

Authors:  Matthew J Binnicker
Journal:  J Clin Microbiol       Date:  2015-12       Impact factor: 5.948

2.  Rationale of using multiplex polymerase chain reaction (PCR) panels for etiological diagnosis of infective diarrhea in the tropics.

Authors:  Ujjala Ghoshal; Nidhi Tejan
Journal:  Indian J Gastroenterol       Date:  2018-09

Review 3.  Molecular Diagnostic Advances in Transplant Infectious Diseases.

Authors:  Brittany A Young; Kimberly E Hanson; Carlos A Gomez
Journal:  Curr Infect Dis Rep       Date:  2019-11-26       Impact factor: 3.725

Review 4.  Small Intestinal Infections.

Authors:  Khushboo Munot; Donald P Kotler
Journal:  Curr Gastroenterol Rep       Date:  2016-06

Review 5.  Syndromic Panel-Based Testing in Clinical Microbiology.

Authors:  Poornima Ramanan; Alexandra L Bryson; Matthew J Binnicker; Bobbi S Pritt; Robin Patel
Journal:  Clin Microbiol Rev       Date:  2017-11-15       Impact factor: 26.132

6.  Multi-organism gastrointestinal polymerase chain reaction positivity among pediatric transplant vs non-transplant populations: A single-center experience.

Authors:  John M Stone; Andrew Savage; Michelle Hudspeth; Katherine Twombley; Nagraj Kasi; Jose Antonio Quiros; Ricardo A Arbizu; Scott Curry
Journal:  Pediatr Transplant       Date:  2020-07-08

7.  A Gastrointestinal PCR Panel Improves Clinical Management and Lowers Health Care Costs.

Authors:  Stacy G Beal; Elizabeth E Tremblay; Steven Toffel; Lymaries Velez; Kenneth H Rand
Journal:  J Clin Microbiol       Date:  2017-12-26       Impact factor: 5.948

8.  Point-Counterpoint: A Nucleic Acid Amplification Test for Streptococcus pyogenes Should Replace Antigen Detection and Culture for Detection of Bacterial Pharyngitis.

Authors:  Bobbi S Pritt; Robin Patel; Thomas J Kirn; Richard B Thomson
Journal:  J Clin Microbiol       Date:  2016-07-20       Impact factor: 5.948

9.  Evaluation of the BioFire FilmArray® GastrointestinalPanel in a Midwestern Academic Hospital.

Authors:  C N Murphy; R C Fowler; P C Iwen; P D Fey
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-12-12       Impact factor: 3.267

10.  Comparison of three multiplex gastrointestinal platforms for the detection of gastroenteritis viruses.

Authors:  Preeti Chhabra; Nicole Gregoricus; Geoffrey A Weinberg; Natasha Halasa; James Chappell; Ferdaus Hassan; Rangaraj Selvarangan; Slavica Mijatovic-Rustempasic; M Leanne Ward; Michael Bowen; Daniel C Payne; Jan Vinjé
Journal:  J Clin Virol       Date:  2017-09-01       Impact factor: 3.168

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.